Document Classification

Section Type: RESULTS

Text: Patients receiving losartan had reductions in the following without a difference in the incidence of myocardial infarction : cardiovascular mortality (8. 7 vs 16. 9 events per 1000 patient-years ; RR, 0. 54 ; 95 % CI, 0. 34-0. 87 ; P =. 01), nonfatal and fatal stroke (10. 6 vs 18. 9 events per 1000 patient-years ; RR, 0. 60 ; 95 % CI, 0. 38-0. 92 ; P =. 02), new-onset diabetes (12. 6 vs 20. 1 events per 1000 patient-years ; RR, 0. 62 ; 95 % CI, 0. 40-0. 97 ; P =. 04), and total mortality (21. 2 vs 30. 2 events per 1000 patient-years ; RR, 0. 72 ; 95 % CI, 0. 53-1. 00 ; P =. 046).